<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308787</url>
  </required_header>
  <id_info>
    <org_study_id>CTS-5052</org_study_id>
    <nct_id>NCT02308787</nct_id>
  </id_info>
  <brief_title>Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions</brief_title>
  <acronym>PLTD</acronym>
  <official_title>Multicenter, Retrospective Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for Platelet Depletion Procedures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Terumo BCT</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Terumo BCT</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter, Retrospective Data Collection of Routine Clinical Use with the Spectra Optia®
      Apheresis System for Platelet Depletion Procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, retrospective data collection to evaluate the in routine use
      performance and safety of platelet depletions performed via the Spectra Optia system. Data
      collection will include procedures in 2- 3 different centers in Europe done between November
      2011 and April 2014.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change in Platelet (PLT) Count in Patient Blood Following Apheresis Procedure</measure>
    <time_frame>on average this will be within 15 minutes after the end of the procedure</time_frame>
    <description>(PLTpre - PLTpost) / PLTpre x 100%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of Processed Platelets (PLT) Which Are Collected i.e. Collection Efficiency for Platelets Achieved by Spectra Optia.</measure>
    <time_frame>on average this will be within 15 minutes after the end of the procedure</time_frame>
    <description>(PLT/µL product x product volume) / ((PLTpre + PLTpost) / 2) x total processed blood volume)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>during the apheresis procedure (from the moment the patient is connected until he is disconnected from the device) and device or procedure related adverse events until discharge from Apheresis Unit (On average, half hour after end of procedure).</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Patient's Platelet Count Pre-depletion Procedure</measure>
    <time_frame>Prior to each Spectra Optia Apheresis Procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient's Platelet Count Post-depletion Procedure</measure>
    <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patients WBC Count Pre-depletion Procedure</measure>
    <time_frame>Prior to each Spectra Optia Apheresis Procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient's WBC Count Post-depletion Procedure</measure>
    <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Whole Blood Processed (mL)</measure>
    <time_frame>Post each Spectra Optia Apheresis Procedure</time_frame>
    <description>Volume of patients blood processed during the apheresis procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Average Inlet Flow Rate</measure>
    <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Procedure Duration</measure>
    <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Waste Bag Volume</measure>
    <time_frame>Post each Spectra Optia Apheresis Procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Total Blood Volume (TBV) Processed</measure>
    <time_frame>Post each Spectra Optia Apheresis Procedure</time_frame>
    <description>The number of times the patient's total blood volume is processed during the apheresis procedure.</description>
  </other_outcome>
  <enrollment type="Actual">12</enrollment>
  <condition>Thrombocythemia</condition>
  <condition>Myeloproliferative Disease</condition>
  <condition>Thrombocytosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectra Optia Apheresis System</intervention_name>
    <description>Platelet Depletion</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have undergone platelet depletion via the Spectra Optia System and who were
        likely to have had blood disorders, such as essential thrombocythemia, a myeloproliferative
        disease, or reactive (secondary) thrombocytosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients having received a minimum of one platelet depletion procedure via the Spectra
             Optia system.

          -  Availability of complete blood count results prior to starting and after completing
             the platelet depletion procedure via the Spectra Optia system.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond P Goodrich, PhD</last_name>
    <role>Study Director</role>
    <affiliation>VP, Scientific and Clinical Affairs; Chief Science Officer-BBT</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pécs</name>
      <address>
        <city>Pécs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Hungary</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <results_first_submitted>February 3, 2016</results_first_submitted>
  <results_first_submitted_qc>May 10, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 15, 2016</results_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>platelet depletion</keyword>
  <keyword>apheresis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombocytosis</mesh_term>
    <mesh_term>Myeloproliferative Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
          <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12">Data were collected from 20 PLTD procedures performed in 12 subjects</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12">Data were collected from 20 PLTD procedures performed in 12 subjects</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.Data were collected from 20 PLTD procedures performed in 12 subjects, which constituted the Full and Safety Analysis Sets.</population>
      <group_list>
        <group group_id="B1">
          <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
          <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age (years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.3" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hungary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.6" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163.9" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Blood Volume</title>
          <description>Estimated by Nadler’s formula for total blood volume of a human based on gender, height, and weight.</description>
          <units>Liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.0" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosis</title>
          <units>pariticpants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Essential thrombocythaemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chronic myeloid leukaemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myelodysplastic/myeloproliferative neoplasm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Polycythaemia vera</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Platelet (PLT) Count in Patient Blood Following Apheresis Procedure</title>
        <description>(PLTpre - PLTpost) / PLTpre x 100%</description>
        <time_frame>on average this will be within 15 minutes after the end of the procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Platelet (PLT) Count in Patient Blood Following Apheresis Procedure</title>
          <description>(PLTpre - PLTpost) / PLTpre x 100%</description>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>% change in PLT count in subject blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-58.2" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent of Processed Platelets (PLT) Which Are Collected i.e. Collection Efficiency for Platelets Achieved by Spectra Optia.</title>
        <description>(PLT/µL product x product volume) / ((PLTpre + PLTpost) / 2) x total processed blood volume)</description>
        <time_frame>on average this will be within 15 minutes after the end of the procedure</time_frame>
        <population>At Site 2, percent processed platelets could only be calculated for 1 procedure in Subject 214; no waste bag (depletion product) platelet counts were available for the other 9 procedures performed at Site 2.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Processed Platelets (PLT) Which Are Collected i.e. Collection Efficiency for Platelets Achieved by Spectra Optia.</title>
          <description>(PLT/µL product x product volume) / ((PLTpre + PLTpost) / 2) x total processed blood volume)</description>
          <population>At Site 2, percent processed platelets could only be calculated for 1 procedure in Subject 214; no waste bag (depletion product) platelet counts were available for the other 9 procedures performed at Site 2.</population>
          <units>% of processed platelets</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.8" spread="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Adverse Events</title>
        <time_frame>during the apheresis procedure (from the moment the patient is connected until he is disconnected from the device) and device or procedure related adverse events until discharge from Apheresis Unit (On average, half hour after end of procedure).</time_frame>
        <population>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <population>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</population>
          <units>Number of subjects with at least 1 AE</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patient's Platelet Count Pre-depletion Procedure</title>
        <time_frame>Prior to each Spectra Optia Apheresis Procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient's Platelet Count Pre-depletion Procedure</title>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>cells x 10^3/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1740.7" spread="744.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patient's Platelet Count Post-depletion Procedure</title>
        <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient's Platelet Count Post-depletion Procedure</title>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>cells x 10^3/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="717.2" spread="336"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patients WBC Count Pre-depletion Procedure</title>
        <time_frame>Prior to each Spectra Optia Apheresis Procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Patients WBC Count Pre-depletion Procedure</title>
          <units>cells x 10^9/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9" spread="18.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patient's WBC Count Post-depletion Procedure</title>
        <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient's WBC Count Post-depletion Procedure</title>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>cells x 10^9/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="6.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Whole Blood Processed (mL)</title>
        <description>Volume of patients blood processed during the apheresis procedure.</description>
        <time_frame>Post each Spectra Optia Apheresis Procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Whole Blood Processed (mL)</title>
          <description>Volume of patients blood processed during the apheresis procedure.</description>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6652.3" spread="856.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Average Inlet Flow Rate</title>
        <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Inlet Flow Rate</title>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.7" spread="8.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Procedure Duration</title>
        <time_frame>Participants were followed for the duration of the procedure and an average of 2.5 hours after the procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Duration</title>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144.5" spread="17.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Waste Bag Volume</title>
        <time_frame>Post each Spectra Optia Apheresis Procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Waste Bag Volume</title>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="669.8" spread="248.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Total Blood Volume (TBV) Processed</title>
        <description>The number of times the patient's total blood volume is processed during the apheresis procedure.</description>
        <time_frame>Post each Spectra Optia Apheresis Procedure</time_frame>
        <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
            <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Blood Volume (TBV) Processed</title>
          <description>The number of times the patient's total blood volume is processed during the apheresis procedure.</description>
          <population>Data were collected for 12 subjects who underwent a total of 20 PLTD procedures at 2 European sites.</population>
          <units>Number of TBVs processed</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>procedures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event (AE) data (including serious adverse events [SAEs]) were collected from the time of the start of the PLTD procedure until discharge from the Apheresis Unit.</time_frame>
      <desc>Adverse events were graded using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03, and coded using the Medical Dictionary for Regulatory Activities (MedDRA®, Version 17.0).</desc>
      <group_list>
        <group group_id="E1">
          <title>Subjects Who Received a Minimum of 1 PLTD Procedure u</title>
          <description>Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA®, Version 17.</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>White blood cell count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Study Site reserves the right to publish the results of its work on the Study. Study Site and the PI agree to submit copies of any manuscript/abstract proposed for publication to Sponsor at least 30 days in advance of the presentation. Sponsor may require the delay of publication for no longer than 90 days for the purpose of filing patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT</name_or_title>
      <organization>Terumo BCT</organization>
      <phone>(303) 231-4357</phone>
      <email>Ray.Goodrich@terumobct.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

